Pathogenic BRCA1 and BRCA2 germ line mutations were found in approximately 17% of the index patients with BC who met the inclusion criteria of the German Consortium for Hereditary Breast and Ovarian Cancer (GC‐HBOC) for germ line testing 2. This evidence concerns the gene BRCA2 and breast cancer.